Wills Hughes-wilson

Ms. Wills Hughes-Wilson serves as Senior Vice President and Chief Patient Access Officer of Swedish Orphan Biovitrum AB and served as its Patient Access Officer. Ms. Hughes-Wilson served as the Chief Patient Access Officer and Vice President at External Affairs at Swedish Orphan Biovitrum AB. Ms. Hughes-Wilson served as Head of Government Affairs, Communications, Patient Access Programs and Corporate Social Responsibility and Vice President of Swedish Orphan Biovitrum AB. Ms. Hughes-Wilson served as Head of Government Affairs and Policy at Swedish Orphan Biovitrum AB. She served as Vice President of Government Affairs and Policy at Swedish Orphan Biovitrum AB. Prior to Swedish Orphan iovitrum AB, Ms. Hughes-Wilson served as Vice President of Health/Market Access Policy for Europe at Genzyme Corporation. She joined Genzyme in 2005. Prior to Genzyme, she served as an Executive Director of Emerging Biopharmaceutical Enterprises. She has also worked in the animal health/veterinary medicines industry and at Ernst and Young Consulting. Ms. Hughes-Wilson has Honors graduate in Law from University of Durham in the UK.